πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 710 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8338457

Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agoni

The United States of America as represented by the Secretary of the Department of Human Services Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8338424

Guanidine-containing compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8323617

Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic aci

ANIKA THERAPEUTICS, INC. Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8314122

Using of organic solvents in wet granulation of moxifloxacin

Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Β· Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8309525

Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration

The Regents of the University of California Β· Granted Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8309766

Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production there

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU β€œPHARMENTERPRISES” Β· Granted Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8273751

Organic compounds

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8273750

Organic compounds

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8257719

Oral care layer and related method of manufacture

Ranir, LLC Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8258274

Vaccines containing canine parvovirus genetic variants

The Board of Regents for Oklahoma State University Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8236288

Melanin modification compositions and methods of use

SkinMedica, Inc. Β· Granted Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8227583

Vaccines containing canine parvovirus genetic variants

The Board of Regents for Oklahoma State University Β· Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8211941

Antagonists of the transient receptor potential vanilloid 1 and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8197823

Vaccine for porcine reproductive and respiratory syndrome, a preparion method and use ther

China Animal Disease Control Center Β· Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8198304

Guanidine-containing compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8198042

CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8188055

Inactivators of O6-alkylguanine-DNA alkyltransferase

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8173120

Method of preventing reduced feed intake in animals and treatment of disease conditions

Precision Nutrition Pty Ltd Β· Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8148328

Salicylanilides enhance oral delivery of therapeutic peptides

The Regents of the University of California Β· Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8124084

Compositions and methods for immunomodulation in an organism using IL-15 and soluble IL-15

UNIVERSITY OF CONNECTICUT Β· Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8124120

Crosslinked hyaluronic acid compositions for tissue augmentation

ANIKA THERAPEUTICS, INC. Β· Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8101572

Methods for promoting wound healing and/or reducing scar formation

Arizona Board of Regents, A Corporate Body Organized Under Arizona Law Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8088908

Humanized anti-prostate stem cell antigen monoclonal antibody

The Regents of the University of California Β· Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8084058

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted